REPORT ID 10271

Global Sustained Release Ocular Drug Delivery Systems Sales Market Report 2017

Publish Date
16-Nov-17
Pages
115
Format
Electronic (PDF)

In this report, the global Sustained Release Ocular Drug Delivery Systems market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Sustained Release Ocular Drug Delivery Systems for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Sustained Release Ocular Drug Delivery Systems market competition by top manufacturers/players, with Sustained Release Ocular Drug Delivery Systems sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    pSivida
    Allergan
    Icon Bioscience
    Ocular Therapeutix
    Neurotech Pharmaceuticals
    Santen Pharmaceutical
    Aciont Inc.
    Envisia Therapeutics
    GrayBug
    Innocore Pharmaceuticals
    OHR Pharmaceuticals
    PolyActiva
    TheraKine
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Liposome
    Microcapsules/Nanocapsules
    Microspheres/Nanosptheres
    Implants
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Cataract
    Glaucoma
    Corneal Transplantation
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Sustained Release Ocular Drug Delivery Systems Sales Market Report 2017
1 Sustained Release Ocular Drug Delivery Systems Market Overview
    1.1 Product Overview and Scope of Sustained Release Ocular Drug Delivery Systems
    1.2 Classification of Sustained Release Ocular Drug Delivery Systems by Product Category
        1.2.1 Global Sustained Release Ocular Drug Delivery Systems Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Sustained Release Ocular Drug Delivery Systems Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Liposome
        1.2.4 Microcapsules/Nanocapsules
        1.2.5 Microspheres/Nanosptheres
        1.2.6 Implants
    1.3 Global Sustained Release Ocular Drug Delivery Systems Market by Application/End Users
        1.3.1 Global Sustained Release Ocular Drug Delivery Systems Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Cataract
        1.3.3 Glaucoma
        1.3.4 Corneal Transplantation
        1.3.5 Others
    1.4 Global Sustained Release Ocular Drug Delivery Systems Market by Region
        1.4.1 Global Sustained Release Ocular Drug Delivery Systems Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Sustained Release Ocular Drug Delivery Systems Status and Prospect (2012-2022)
        1.4.3 China Sustained Release Ocular Drug Delivery Systems Status and Prospect (2012-2022)
        1.4.4 Europe Sustained Release Ocular Drug Delivery Systems Status and Prospect (2012-2022)
        1.4.5 Japan Sustained Release Ocular Drug Delivery Systems Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Sustained Release Ocular Drug Delivery Systems Status and Prospect (2012-2022)
        1.4.7 India Sustained Release Ocular Drug Delivery Systems Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Sustained Release Ocular Drug Delivery Systems (2012-2022)
        1.5.1 Global Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2012-2022)
        1.5.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2012-2022)

2 Global Sustained Release Ocular Drug Delivery Systems Competition by Players/Suppliers, Type and Application
     2.1 Global Sustained Release Ocular Drug Delivery Systems Market Competition by Players/Suppliers
        2.1.1 Global Sustained Release Ocular Drug Delivery Systems Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Sustained Release Ocular Drug Delivery Systems (Volume and Value) by Type
        2.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales and Market Share by Type (2012-2017)
        2.2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Market Share by Type (2012-2017)
    2.3 Global Sustained Release Ocular Drug Delivery Systems (Volume and Value) by Region
        2.3.1 Global Sustained Release Ocular Drug Delivery Systems Sales and Market Share by Region (2012-2017)
        2.3.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Market Share by Region (2012-2017)
    2.4 Global Sustained Release Ocular Drug Delivery Systems (Volume) by Application

3 United States Sustained Release Ocular Drug Delivery Systems (Volume, Value and Sales Price)
    3.1 United States Sustained Release Ocular Drug Delivery Systems Sales and Value (2012-2017)
        3.1.1 United States Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2012-2017)
        3.1.2 United States Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2012-2017)
        3.1.3 United States Sustained Release Ocular Drug Delivery Systems Sales Price Trend (2012-2017)
    3.2 United States Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Players
    3.3 United States Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Type
    3.4 United States Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Application

4 China Sustained Release Ocular Drug Delivery Systems (Volume, Value and Sales Price)
    4.1 China Sustained Release Ocular Drug Delivery Systems Sales and Value (2012-2017)
        4.1.1 China Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2012-2017)
        4.1.2 China Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2012-2017)
        4.1.3 China Sustained Release Ocular Drug Delivery Systems Sales Price Trend (2012-2017)
    4.2 China Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Players
    4.3 China Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Type
    4.4 China Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Application

5 Europe Sustained Release Ocular Drug Delivery Systems (Volume, Value and Sales Price)
    5.1 Europe Sustained Release Ocular Drug Delivery Systems Sales and Value (2012-2017)
        5.1.1 Europe Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2012-2017)
        5.1.2 Europe Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Sustained Release Ocular Drug Delivery Systems Sales Price Trend (2012-2017)
    5.2 Europe Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Players
    5.3 Europe Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Type
    5.4 Europe Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Application

6 Japan Sustained Release Ocular Drug Delivery Systems (Volume, Value and Sales Price)
    6.1 Japan Sustained Release Ocular Drug Delivery Systems Sales and Value (2012-2017)
        6.1.1 Japan Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2012-2017)
        6.1.2 Japan Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Sustained Release Ocular Drug Delivery Systems Sales Price Trend (2012-2017)
    6.2 Japan Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Players
    6.3 Japan Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Type
    6.4 Japan Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Application

7 Southeast Asia Sustained Release Ocular Drug Delivery Systems (Volume, Value and Sales Price)
    7.1 Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales and Value (2012-2017)
        7.1.1 Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Price Trend (2012-2017)
    7.2 Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Players
    7.3 Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Type
    7.4 Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Application

8 India Sustained Release Ocular Drug Delivery Systems (Volume, Value and Sales Price)
    8.1 India Sustained Release Ocular Drug Delivery Systems Sales and Value (2012-2017)
        8.1.1 India Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2012-2017)
        8.1.2 India Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2012-2017)
        8.1.3 India Sustained Release Ocular Drug Delivery Systems Sales Price Trend (2012-2017)
    8.2 India Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Players
    8.3 India Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Type
    8.4 India Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Application

9 Global Sustained Release Ocular Drug Delivery Systems Players/Suppliers Profiles and Sales Data
    9.1 pSivida
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 pSivida Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Allergan
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Icon Bioscience
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Ocular Therapeutix
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Neurotech Pharmaceuticals
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Santen Pharmaceutical
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Aciont Inc.
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Envisia Therapeutics
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 GrayBug
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 GrayBug Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 Innocore Pharmaceuticals
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview
    9.11 OHR Pharmaceuticals
    9.12 PolyActiva
    9.13 TheraKine

10 Sustained Release Ocular Drug Delivery Systems Maufacturing Cost Analysis
    10.1 Sustained Release Ocular Drug Delivery Systems Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Sustained Release Ocular Drug Delivery Systems
    10.3 Manufacturing Process Analysis of Sustained Release Ocular Drug Delivery Systems

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Sustained Release Ocular Drug Delivery Systems Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Sustained Release Ocular Drug Delivery Systems Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Sustained Release Ocular Drug Delivery Systems Market Forecast (2017-2022)
    14.1 Global Sustained Release Ocular Drug Delivery Systems Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Sustained Release Ocular Drug Delivery Systems Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Sustained Release Ocular Drug Delivery Systems Price and Trend Forecast (2017-2022)
    14.2 Global Sustained Release Ocular Drug Delivery S